Cargando…
Protracted complete response after limited checkpoint inhibitor dosing: A case report
Immunotherapy is an important modality in the treatment of many types of malignancy. The optimal duration of treatment with immunotherapy in patients with metastatic malignancies who experience complete responses is not fully understood. Our case demonstrates a protracted complete response in a pati...
Autores principales: | Sember, Quinne, Sigal, Darren |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10547855/ https://www.ncbi.nlm.nih.gov/pubmed/37799570 http://dx.doi.org/10.1002/ccr3.7793 |
Ejemplares similares
-
A case of protracted eosinopenia after a single subcutaneous dose of benralizumab
por: Miranda, Joana, et al.
Publicado: (2022) -
A review of treatments targeting DNA-repair gene defects in metastatic castration resistant prostate cancer
por: Maslov, Diana V., et al.
Publicado: (2023) -
Atypical Ketoacidosis and Protracted Hyperglycosuria after Treatment with Ipragliflozin, an SGLT2 Inhibitor
por: Miyauchi, Masaaki, et al.
Publicado: (2017) -
Concealed complete response in melanoma patients under therapy with immune checkpoint inhibitors: two case reports
por: Schliep, Stefan, et al.
Publicado: (2018) -
Intubation following high-dose rocuronium in a cat with protracted laryngospasm
por: Doodnaught, Graeme M, et al.
Publicado: (2017)